Our Patented RENOVITE^® Nanoclay Platform

Renovos is backed by decades of academic research and deep understanding of stem cells, tissue engineering, biomaterials and the clinical orthobiologic fields.

The core focus of Renovos is addressing the unmet clinical needs within regenerative medicine and therapeutics/biologics delivery by developing a proprietary platform technology based on synthetic nanoclay, RENOVITE^®.  RENOVITE^® is an injectable, bioactive and degradable carrier that offers unprecedented retention of active molecules at the delivery site. 

This leads to dose reduction, lower cost of goods and improved safety for potent therapeutics and biologics in easy-to-handle formulations.